EPSRC Optimising Knee Therapies annual conference 2021

  • Date:
  • Time: 13:00 to 19:00
  • Location: Virtual Platform

On Tuesday 20th April 2021 we will be holding our annual conference to report progress on our EPSRC Progamme grant on optimising knee therapies. Despite restrictions on our lab access during lockdown, we have been able to make progress across all the workstreams and we look forward to presenting and discussing our latest research with colleagues across all fields.

This year, the event will be held virtually which we hope will provide greater opportunity for attendance.

We are going to focus on the clinical applications of the methods we have been developed and we are pleased to welcome three of our clinical colleagues as keynote presenters to frame each session. The detailed programme will be available shortly but an outline is indicated below.

If you are interested in attending and contributing to our discussions please contact us at : menimbe@leeds.ac.uk

Keynote speakers:

Philip Conaghan – Deputy Director of the NIHR Leeds Biomedical Research Centre; Honorary Consultant Rheumatologist for LTHT; NIHR Senior Investigator Emeritus

Mike McNicholas – Consultant Orthopaedic Surgeon at Liverpool University Hospitals Broadgreen; President of the UK Biological Knee Society

Sanjeev Anand – Consultant Orthopaedic Surgeon, Leeds Teaching Hospitals NHS Trust

Session 1: Cartilage and Bone

Presentations will outline the progress made on experimental cadaveric knee simulators, specimen-specific computational modelling methods, and parallel imaging work, and their applications to evaluate the biomechanical performance of new surgical interventions, including work on decellularised osteochondral scaffolds and self-assembling peptides for cartilage repair.

Session 2: Ligaments

We will showcase work on decellularised tissues for ligament reconstruction and associated testing approaches.

Session 3: Meniscus

Presentations will outline methods that are under development to evaluate meniscus replacement allografts including in vitro simulation and finite element modelling methods.